Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Wnt1 inducible signaling pathway protein-1 (WISP1) may play an important role in promoting carcinogenesis. However, the biological function and underlying mechanism of WISP1 in pancreatic carcinogenesis still remains enigmatic. In this study, immunochemistry staining showed that protein levels of WISP1 were more significantly upregulated in pancreatic ductal adenocarcinoma (PDAC) tissues with
Tp53
mutation than in PDAC tissues with
Tp53
wild-type. In addition, a significant correlation was observed between increased malignant phenotype of tumors from well-differentiated adenocarcinoma tissues to moderately- or poorly-differentiated adenocarcinoma tissues shifting from cytoplasmic expression to nuclear accumulation of WISP1. Interestingly,
WISP1
expression was correlated with the poor prognosis in PDAC patients with
Tp53
mutation. Also, the biological function analysis showed that
WISP1
may act as a potential oncogene in PDAC cells. In addition, immunofluorescence analysis showed that
Tp53
mutation promoted
WISP1
expression in
PanIN
and PDAC cells, while Siah E3
Ubiquitin
Protein Ligase 1 (
Siah1
) inhibited
WISP1
expression in PDAC cells. Moreover, through immunoprecipitation, immunoblotting analysis,
in vitro
binding assay, and ubiquitination assay, we found that
Tp53
mutation inhibited ubiquitination and degradation of Siah1-dependent WISP1. Therefore,
Tp53
mutation-Siah1-WISP1 is a new signaling pathway, playing an important role in pancreatic carcinogenesis.
...
PMID:
Tp53
Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis. 3012 32